Oramed Pharmaceuticals (ORMP) Accounts Payables (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted Accounts Payables of $8.5 million for Q1 2026, up 1823.48% on a QoQ basis from $443000.0 in Q4 2025, and up 61.54% year-over-year from $5.3 million in Q1 2025.
Oramed Pharmaceuticals (ORMP) Accounts Payables (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Accounts Payables history runs 16 years deep, the most recent figure standing at $8.5 million for Q1 2026.
- Quarterly Accounts Payables rose 61.54% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (up 61.54% YoY) and the FY2025 annual result came in at $443000.0, down 91.38% from the prior year.
- Accounts Payables was $8.5 million for Q1 2026 at Oramed Pharmaceuticals, up from $443000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $8.5 million in Q1 2026 and bottomed at $443000.0 in Q4 2025.
- A 5-year average of $3.4 million and a median of $3.5 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables surged 832.85% — and 2025, when it plunged 91.38%.
- Oramed Pharmaceuticals' Accounts Payables stood at $4.2 million in 2022, then plunged by 86.75% to $551000.0 in 2023, then jumped by 832.85% to $5.1 million in 2024, then plunged by 91.38% to $443000.0 in 2025, then surged by 1823.48% to $8.5 million in 2026.
- Business Quant data shows ORMP's Accounts Payables at $8.5 million in Q1 2026, $443000.0 in Q4 2025, and $4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 8.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.52 Mn |
| Dec 31, 2025 | 443,000.00 |
| Sep 30, 2025 | 4.86 Mn |
| Jun 30, 2025 | 715,000.00 |
| Mar 31, 2025 | 5.28 Mn |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 3.48 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 551,000.00 |
| Sep 30, 2023 | 2.56 Mn |
| Jun 30, 2023 | 828,000.00 |
| Mar 31, 2023 | 4.06 Mn |
| Dec 31, 2022 | 4.16 Mn |
| Sep 30, 2022 | 4.21 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 3.31 Mn |
| Nov 30, 2021 | 4.76 Mn |
| Aug 31, 2021 | 3.79 Mn |
| May 31, 2021 | 2.86 Mn |